Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral Challenge-Reference-Cited by-同舟云学术

Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral Challenge

Published:2016-08-15 Issue:8 Volume:11 Page:e0161193
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Magini Diletta,Giovani Cinzia,Mangiavacchi Simona,Maccari Silvia,Cecchi Raffaella,Ulmer Jeffrey B.,De Gregorio Ennio,Geall Andrew J.,Brazzoli Michela,Bertholet Sylvie

Funder

Defense Advanced Research Projects Agency

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference68 articles.

1. The annual impact of seasonal influenza in the US: measuring disease burden and costs;NA Molinari;Vaccine,2007

2. Current and next generation influenza vaccines: Formulation and production strategies;PC Soema;European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik eV,2015

3. Mismatch between the 1997/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly;JC de Jong;Journal of medical virology,2000

4. Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong;BJ Cowling;Clinical infectious diseases: an official publication of the Infectious Diseases Society of America,2010

5. Antibody response against heterogeneous circulating influenza virus strains elicited by MF59- and non-adjuvanted vaccines during seasons with good or partial matching between vaccine strain and clinical isolates;F Ansaldi;Vaccine,2010

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Semliki Forest Virus (SFV) Self-Amplifying RNA Delivered to J774A.1 Macrophage Lineage by Its Association with a Purified Recombinant SFV Capsid Protein;International Journal of Molecular Sciences;2024-07-18

2. Recent Advances, Approaches and Challenges in the Development of Universal Influenza Vaccines;Influenza and Other Respiratory Viruses;2024-03

3. Advanced nanoscale delivery systems for mRNA-based vaccines;Biochimica et Biophysica Acta (BBA) - General Subjects;2024-03

4. RNA therapeutics for infectious diseases;Progress in Molecular Biology and Translational Science;2024

5. Nanotechnology in vaccines and personalized medicine;Comprehensive Precision Medicine;2024